News Conference News TCT 2025 AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations Todd Neale October 31, 2025
News Conference News TCT 2025 INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time Michael O'Riordan October 29, 2025
Presentation TCT 2025 Regulatory Approvals for Therapies for Patients with “Not Suitable for Conventional Therapy?" Presenter: Jeffrey Popma October 28, 2025
Presentation TCT 2025 TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis Presenter: Thomas E. Waggoner October 28, 2025
Presentation TCT 2025 Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions Presenter: Mitchell W. Krucoff October 28, 2025
Presentation TCT 2025 Electrosurgical Tools in Structural Heart Interventions: How to Drive Best Practices, Device Development, and Regulatory Approval Presenter: Adam B. Greenbaum October 28, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
Presentation TCT 2025 Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval Presenter: Sreekanth Vemulapalli October 27, 2025
Presentation TCT 2025 TCT 704: Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients of Historically Underrepresented Racial and Ethnic Groups: A Sub-analysis of the HEAL-LAA Post Approval Study Presenter: Seun Alli October 27, 2025
Presentation TCT 2025 Comparative Outcomes of ICE vs. TEE Guided LACC with Amulet Device: Insights from EMERGE LAA Post-Approval Study Presenter: Mohamad A. Alkhouli October 26, 2025
Presentation TCT 2025 TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study Presenter: Christina Lalani October 26, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2024 Embolic Protection Benefits Varied by Geography in PROTECTED TAVR Todd Neale October 31, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
Presentation TCT 2024 TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study Presenter: Santiago Garcia October 30, 2024
Presentation TCT 2024 Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study Presenter: Seun Alli October 30, 2024
Presentation TCT 2024 One-Year Real-World Outcomes with the Amulet LAAO: The EMERGE LAA Post-Approval Study Presenter: Atman Shah October 30, 2024
Presentation TCT 2024 How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI Presenter: Suzanne Arnold October 30, 2024
News Conference News TCT 2024 ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation Yael L. Maxwell October 29, 2024